ResearchNivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer
ResearchA Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma
ResearchSpatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia
ResearchDifferential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal
ResearchModeling cellular influence delineates functionally relevant cellular neighborhoods in primary and metastatic pancreatic ductal adenocarcinoma
ResearchHuman interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories
ResearchNeoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment
ResearchA phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
ResearchPASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
ResearchImmune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy
ResearchErratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
ResearchBIWT: a bioinformatics walkthrough for embedding spatial multiomics in agent-based models for virtual cells
ResearchComparative assessment of physiochemical metrics for the clustering of adaptive immune receptor repertoires
ResearchQuantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy
